BiotechTube
Home/Galectin Therapeutics/Pol F. Boudes, MD
PF

Pol F. Boudes, MD

Chief Medical Officer

Galectin Therapeutics

Therapeutic Areas

Chronic Liver DiseaseOncology

Galectin Therapeutics Pipeline

DrugIndicationPhase
Belapectin (GR-MD-02)MASH Cirrhosis with Portal HypertensionPhase 2b/3

Leadership Team at Galectin Therapeutics

JL
Joel Lewis
President & CEO
E(
Elisabeth (Lisa) R. G. Wright, CPA
Chief Financial Officer
HB
Henry Brem, M.D.
Board of Directors
View full Galectin Therapeutics profile